Literature DB >> 33451991

Optimizing Utilization of Kidneys from Hepatitis C-Positive Kidney Donors.

Venkatesh K Ariyamuthu1, Bekir Tanriover2.   

Abstract

Entities:  

Keywords:  cadaver organ transplantation; glomerular filtration rate; hepatitis; kidney failure; kidney transplantation

Mesh：

Year:  2021        PMID： 33451991      PMCID： PMC7863653          DOI： 10.2215/CJN.19431220

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.

Authors:  Ricardo M La Hoz; Burhaneddin Sandıkçı; Venkatesh K Ariyamuthu; Bekir Tanriover
Journal:  Am J Transplant       Date:  2019-08-07       Impact factor: 8.086

2.  Transplantation of Kidneys from HCV Viremic Donors in the United States: A Missed Opportunity to Inform Clinical Decision Making and Health Policy.

Authors:  John S Gill; Richard N Formica; Josh Levitsky
Journal:  J Am Soc Nephrol       Date:  2019-09-12       Impact factor: 10.121

3.  The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.

Authors:  J Levitsky; R N Formica; R D Bloom; M Charlton; M Curry; J Friedewald; J Friedman; D Goldberg; S Hall; M Ison; T Kaiser; D Klassen; G Klintmalm; J Kobashigawa; A Liapakis; K O'Conner; P Reese; D Stewart; N Terrault; N Theodoropoulos; J Trotter; E Verna; M Volk
Journal:  Am J Transplant       Date:  2017-07-01       Impact factor: 8.086

4.  Reevaluation of the Kidney Donor Risk Index.

Authors:  Yingchao Zhong; Douglas E Schaubel; John D Kalbfleisch; Valarie B Ashby; Panduranga S Rao; Randall S Sung
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

5.  Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial.

Authors:  Peter P Reese; Peter L Abt; Emily A Blumberg; Vivianna M Van Deerlin; Roy D Bloom; Vishnu S Potluri; Matthew Levine; Paige Porrett; Deirdre Sawinski; Susanna M Nazarian; Ali Naji; Richard Hasz; Lawrence Suplee; Jennifer Trofe-Clark; Anna Sicilia; Maureen McCauley; Caren Gentile; Jennifer Smith; Bijan A Niknam; Melissa Bleicher; K Rajender Reddy; David S Goldberg
Journal:  Ann Intern Med       Date:  2018-08-07       Impact factor: 25.391

6.  Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.

Authors:  L Sibulesky; C E Kling; C Blosser; C K Johnson; A P Limaye; R Bakthavatsalam; N Leca; J D Perkins
Journal:  Am J Transplant       Date:  2018-03-14       Impact factor: 8.086

7.  Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients.

Authors:  Mark H Eckman; E Steve Woodle; Charuhas V Thakar; Rita R Alloway; Kenneth E Sherman
Journal:  Am J Kidney Dis       Date:  2020-02-17       Impact factor: 8.860

8.  Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.

Authors:  Venkatesh K Ariyamuthu; Burhaneddin Sandikci; Nashila AbdulRahim; Christine Hwang; Malcolm P MacConmara; Ravi Parasuraman; Ahsen Atis; Bekir Tanriover
Journal:  Transpl Infect Dis       Date:  2019-11-26       Impact factor: 2.228

9.  Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States.

Authors:  Su-Hsin Chang; Massini Merzkani; Krista L Lentine; Mei Wang; David A Axelrod; Siddiq Anwar; Mark A Schnitzler; Jason Wellen; William C Chapman; Tarek Alhamad
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-15       Impact factor: 8.237

10.  Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial.

Authors:  Christine M Durand; Mary G Bowring; Diane M Brown; Michael A Chattergoon; Guido Massaccesi; Nichole Bair; Russell Wesson; Ashraf Reyad; Fizza F Naqvi; Darin Ostrander; Jeremy Sugarman; Dorry L Segev; Mark Sulkowski; Niraj M Desai
Journal:  Ann Intern Med       Date:  2018-03-06       Impact factor: 51.598
  10 in total
  2 in total

1.  Liver Outcome in Renal Transplant Recipients Who Acquired Hepatitis C Infection From an Infected Graft: Study Based on Liver Biopsy Findings.

Authors:  Jiten P Kothadia; Anshul Bhalla; Miklos Z Molnar; Rahul Mohan; Vasanthi Balaraman; Manish Talwar; Ryan Helmick; Corey Eymard; Ian Clark; Richa Jain; Thomas W Faust; Jason M Vanatta; James D Eason; Satheesh P Nair
Journal:  Transplant Direct       Date:  2022-05-26

2.  CMV specific T cell immune response in hepatitis C negative kidney transplant recipients receiving transplant from hepatitis C viremic donors and hepatitis C aviremic donors.

Authors:  Ambreen Azhar; Makoto Tsujita; Manish Talwar; Vasanthi Balaraman; Anshul Bhalla; James D Eason; Simonne S Nouer; Keiichi Sumida; Adam Remport; Isaac E Hall; Randi Griffin; George Rofaiel; Miklos Z Molnar
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.